These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3400068)

  • 21. Augmentation of carcinogenesis by N-nitrosobis(2-oxopropyl)amine administered during S phase of the cell cycle in regenerating hamster pancreas.
    Scarpelli DG; Rao MS; Subbarao V
    Cancer Res; 1983 Feb; 43(2):611-6. PubMed ID: 6848182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental induction of pancreatic carcinomas in the hamster with N delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine.
    Longnecker DS; Curphey TJ; Kuhlmann ET; Schaeffer BK
    J Natl Cancer Inst; 1983 Dec; 71(6):1327-36. PubMed ID: 6581365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of pancreatic carcinogenesis in the hamster model. 2. The effect of partial pancreatectomy.
    Pour PM; Donnelly T; Stepan K; Muffly K
    Am J Pathol; 1983 Jan; 110(1):75-82. PubMed ID: 6295175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
    Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
    Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal peptide inhibits the growth of hamster pancreatic cancer but not human pancreatic cancer in vivo.
    Poston GJ; Yao CZ; Upp JR; Alexander RW; Townsend CM; Thompson JC
    Pancreas; 1988; 3(4):439-43. PubMed ID: 3174607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
    Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
    In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
    Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
    Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrically mediated drug delivery for treating subcutaneous and orthotopic pancreatic adenocarcinoma in a hamster model.
    Jaroszeski MJ; Illingworth P; Pottinger C; Hyacinthe M; Heller R
    Anticancer Res; 1999; 19(2A):989-94. PubMed ID: 10368643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accessible standardized intracutaneous implants: pancreatic adenocarcinoma in the Syrian hamster.
    LaMuraglia GM; Abu-Khalaf MM; Malt RA
    Br J Cancer; 1984 Aug; 50(2):235-7. PubMed ID: 6466541
    [No Abstract]   [Full Text] [Related]  

  • 30. GI hormonal changes in diabetes influence pancreatic cancer growth.
    Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
    J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of pancreatic carcinogenesis in the hamster model. X. Effect of streptozotocin.
    Pour PM; Patil K
    J Natl Cancer Inst; 1983 Nov; 71(5):1059-65. PubMed ID: 6316009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor alpha is trophic to pancreatic cancer in vivo.
    Davies N; Kapur P; Gillespie J; Guillou PJ; Poston GJ
    Gut; 1993 Aug; 34(8):1097-8. PubMed ID: 8174961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental pancreatic carcinoma as a model of human pancreatic carcinoma.
    Satake K; Mukai R; Kato Y; Shim K; Umeyama K
    Clin Oncol; 1984 Mar; 10(1):27-34. PubMed ID: 6423332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortivazol increases glucocorticoid receptor expression and inhibits growth of hamster pancreatic cancer (H2T) in vivo.
    Evers BM; Thompson EB; Townsend CM; Lawrence JL; Johnson B; Srinivasan G; Thompson JC
    Pancreas; 1993 Jan; 8(1):7-14. PubMed ID: 8419910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters.
    Egami H; Tomioka T; Tempero M; Kay D; Pour PM
    Am J Pathol; 1991 Mar; 138(3):557-61. PubMed ID: 2000935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of insulinoma into the diabetic Syrian hamster.
    Reintgen D; Feldman J; Vervaert C; Seigler HF
    Ann Surg; 1980 Jan; 191(1):105-13. PubMed ID: 6243454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental diabetes: effect of streptocotozin on the golden Syrian hamster.
    Miller DL
    Lab Anim Sci; 1990 Sep; 40(5):539-40. PubMed ID: 2170761
    [No Abstract]   [Full Text] [Related]  

  • 38. Carcinoma of the pancreas.
    Levison DA
    J Pathol; 1979 Dec; 129(4):203-23. PubMed ID: 395291
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor effect of positively charged resin in the hamster cheek pouch model.
    Simmons DJ; Seitz PK; Cooper CW; Krukowski M; Townsend CM
    J Biomed Mater Res; 1997 Mar; 34(3):393-400. PubMed ID: 9086409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curative resection of orthotopically implanted pancreatic cancer in Syrian golden hamsters.
    Morioka CY; Saito S; Kita K; Watanabe A
    Int J Pancreatol; 2000 Dec; 28(3):207-13. PubMed ID: 11373058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.